Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2022 11:00 ET | Source: neurocare group AG

neurocare group AG Announces Recent Start of a Phase III Trial Examining the Cost-Effectiveness of TMS for Patients With Exposure Therapy-Resistant OCD

MUNICH, June 08, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
December 07, 2021 09:00 ET | Source: Brain & Behavior Research Foundation

OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation

New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
October 06, 2020 09:00 ET | Source: BrainsWay

BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session

CRESSKILL, N.J. and JERUSALEM, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
August 13, 2020 09:30 ET | Source: Allied Market Research

Lithography Metrology Equipment Market to Reach $681.4 Million by 2026, Says AMR

Portland, OR, Aug. 13, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global lithography metrology equipment market was estimated at $382.6 million in 2018...
July 21, 2020 09:00 ET | Source: BrainsWay Ltd.

BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020

PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
July 21, 2020 09:00 ET | Source: University TMS

University TMS Clinic Now Offering FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

TUSCALOOSA, Ala., July 21, 2020 (GLOBE NEWSWIRE) -- University TMS, a mental health facility specializing in advanced treatments for neurological and psychiatric disorders, is now offering...
June 16, 2020 07:30 ET | Source: BrainsWay Ltd.

BrainsWay Launches New Website to Enhance Mental Health Awareness

PATTERSON, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
April 07, 2020 09:00 ET | Source: The Remedy

The Remedy Is Now Offering Deep Transcranial Magnetic Stimulation (Deep TMS) Therapy to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

VADNAIS HEIGHTS, Minn., April 07, 2020 (GLOBE NEWSWIRE) -- The Remedy, a person-centered mental health care facility offering advanced treatments, announced today that it is now offering BrainsWay’s...
March 04, 2020 13:05 ET | Source: Brain & Behavior Research Foundation

Brain and Behavior Based Strategies in the Treatment of OCD - A Free Webinar from the Brain & Behavior Research Foundation

New York, March 04, 2020 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Brain and Behavior Based Strategies in the Treatment of OCD” on Tuesday, March...
February 20, 2020 09:00 ET | Source: Solace Behavioral Health

Solace Behavioral Health Clinic Hosts Grand Opening to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

TAMPA, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Solace Behavioral Health, a mental health clinic offering advanced treatments for mental health disorders, announced today that it will host an grand...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right